How to confidently navigate your first EMA interactions

Couverture du white paper : How to confidently navigate your first EMA interactions

Planning Your First EMA Interaction?
Start Here.

The European Medicines Agency (EMA) isn’t just the FDA with different forms. From pediatric plans to country-specific pricing, the EU brings its own set of rules-and risks.

This guide walks you through:

  • When and how to engage the EMA through Scientific Advice
  • Timing and structure of your Pediatric Investigation Plan (PIP)
  • Meeting CMC expectations well ahead of submission
  • Building a market-access strategy tailored to EU payers
  • Mapping key stakeholders-from KOLs to HTA bodies

Register to download our white paper